Park Medi World is currently trading at Rs. 150.00, up by 0.55 points or 0.37% from its previous closing of Rs. 149.45 on the BSE.
The scrip opened at Rs. 149.30 and has touched a high and low of Rs. 151.70 and Rs. 146.70 respectively. So far 83505 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 165.75 on 17-Dec-2025 and a 52 week low of Rs. 138.15 on 18-Dec-2025.
Last one week high and low of the scrip stood at Rs. 152.25 and Rs. 142.00 respectively. The current market cap of the company is Rs. 6485.44 crore.
The promoters holding in the company stood at 82.89%, while Institutions and Non-Institutions held 8.63% and 8.48% respectively.
Expanding its footprint in North India, Park Medi World has acquired 250 bedded Krishna Super-speciality Hospital, Bathinda (Hospital), transitioning from managing to fully acquiring the 250-bed Hospital in Bathinda.
The Park Group has been managing operations of Krishna Super-speciality Hospital since July 2025, and has now acquired 100% shareholding from the current promoters in an all-cash deal for Rs 40 crore. This acquisition strengthens Park Group's cluster-based growth model, driving operational synergies and clinical excellence across North India.
Strategically positioned in the heart of Bathinda, Krishna Super-speciality Hospital serves as a vital healthcare hub for both urban and rural districts, offering a centralized location for multiple super-specialties.
With the addition of this hospital, Park Group increases its hospital capacity and strengthens its infrastructure, supporting its plan to reach a total of 5,260 beds by March 2028.
Park Medi World is the second largest private hospital chain in North India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7738.05 |
| Max Healthcare Inst | 1011.45 |
| Narayana Hrudayalay | 1792.10 |
| Aster DM Healthcare | 744.70 |
| Global Health | 1171.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: